4 patents
Utility
Inhibitors of menin-mll interaction
19 Dec 23
Disclosed herein are heterocyclic compounds that inhibit the binding of menin and MLL or MLL fusion proteins.
Thomas Butler, Jim Palmer, Ravi Upasani, Matthew Welsch, Sridhar Vempati, Brendan Kelly, Edward Painter
Filed: 10 Sep 21
Utility
Substituted pyridines as irreversible inhibitors of menin-MLL interaction
18 Jul 23
Thomas Butler, Jim Palmer, Ravi Upasani, Matthew Welsch, Sridhar Vempati, Brendan Kelly, Edward Painter
Filed: 18 Jun 21
Utility
Inhibitors of menin-MLL interaction
16 Nov 21
Thomas Butler, Jim Palmer, Ravi Upasani, Matthew Welsch, Sridhar Vempati, Brendan Kelly, Edward Painter
Filed: 31 Dec 19
Utility
Substituted pyridines as irreversible inhibitors of menin-MLL interaction
10 Aug 21
Thomas Butler, Jim Palmer, Ravi Upasani, Matthew Welsch, Sridhar Vempati, Brendan Kelly, Edward Painter
Filed: 31 Dec 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first